帕金森病的中央主动脉压和动脉僵硬:一项比较研究。

IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY
Parkinson's Disease Pub Date : 2022-07-12 eCollection Date: 2022-01-01 DOI:10.1155/2022/6723950
Mehmet Balal, Meltem Demirkiran, Saime Paydas
{"title":"帕金森病的中央主动脉压和动脉僵硬:一项比较研究。","authors":"Mehmet Balal,&nbsp;Meltem Demirkiran,&nbsp;Saime Paydas","doi":"10.1155/2022/6723950","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular autonomic dysfunction, which leads to hemodynamic disorders, is commonly observed in patients with Parkinson's disease (PD). Central aortic pressure (CAP) is the systolic blood pressure (SBP) at the root of the aorta. In young people, CAP is lower than peripheral arterial blood pressure. In older people, the difference between CAP and peripheral arterial blood pressure decreases depending on the extent of arterial stiffness (AS). In patients with AS, CAP increases. CAP is thus regarded as an indicator of AS.</p><p><strong>Objective: </strong>To compare CAP and other hemodynamic parameters for AS between patients with Parkinson's disease and control group. We also aimed to evaluate changes in these hemodynamic parameters after the levodopa (LD) intake.</p><p><strong>Methods: </strong>We included 82 patients with PD and 76 healthy controls. Age, sex, disease duration, disease subtype, Hoehn-Yahr stage (H&Y), and nonmotor symptoms (NMS) were documented. TensioMed Software v.3.0.0.1 was used to measure CAP, peripheral arterial blood pressure, pulse pressure (PP), heart rate (HR), mean arterial pressure (MAP), augmentation index (AI), pulse wave velocity, and ejection time. All patients were being treated with LD, and measurements were performed 1 h before and 1 h after LD intake.</p><p><strong>Results: </strong>Baseline peripheral arterial blood pressure and CAP values were significantly higher in the PD group than in the control group (<i>p</i> < 0.001 and <i>p</i>=0.02, respectively). Most cardiac hemodynamic parameters, including peripheral arterial blood pressure and CAP, decreased significantly (<i>p</i> < 0.02 and <i>p</i> < 0.001, respectively) after LD intake in the PD group. Disease subtype, duration, and severity did not affect any of the hemodynamic parameters. When NMS were evaluated, patients with psychosis and dementia showed higher baseline parameters.</p><p><strong>Conclusion: </strong>Loss of postganglionic noradrenergic innervation is well-known with PD. Several cardiac hemodynamic parameters were affected, suggesting cardiac autonomic dysfunction in these patients. The data obtained were independent of disease severity, duration, and subtype. After LD intake, most of these parameters decreased, which might have a positive effect on the vascular burden.</p>","PeriodicalId":19907,"journal":{"name":"Parkinson's Disease","volume":" ","pages":"6723950"},"PeriodicalIF":2.2000,"publicationDate":"2022-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296341/pdf/","citationCount":"0","resultStr":"{\"title\":\"Central Aortic Pressure and Arterial Stiffness in Parkinson's Disease: A Comparative Study.\",\"authors\":\"Mehmet Balal,&nbsp;Meltem Demirkiran,&nbsp;Saime Paydas\",\"doi\":\"10.1155/2022/6723950\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Cardiovascular autonomic dysfunction, which leads to hemodynamic disorders, is commonly observed in patients with Parkinson's disease (PD). Central aortic pressure (CAP) is the systolic blood pressure (SBP) at the root of the aorta. In young people, CAP is lower than peripheral arterial blood pressure. In older people, the difference between CAP and peripheral arterial blood pressure decreases depending on the extent of arterial stiffness (AS). In patients with AS, CAP increases. CAP is thus regarded as an indicator of AS.</p><p><strong>Objective: </strong>To compare CAP and other hemodynamic parameters for AS between patients with Parkinson's disease and control group. We also aimed to evaluate changes in these hemodynamic parameters after the levodopa (LD) intake.</p><p><strong>Methods: </strong>We included 82 patients with PD and 76 healthy controls. Age, sex, disease duration, disease subtype, Hoehn-Yahr stage (H&Y), and nonmotor symptoms (NMS) were documented. TensioMed Software v.3.0.0.1 was used to measure CAP, peripheral arterial blood pressure, pulse pressure (PP), heart rate (HR), mean arterial pressure (MAP), augmentation index (AI), pulse wave velocity, and ejection time. All patients were being treated with LD, and measurements were performed 1 h before and 1 h after LD intake.</p><p><strong>Results: </strong>Baseline peripheral arterial blood pressure and CAP values were significantly higher in the PD group than in the control group (<i>p</i> < 0.001 and <i>p</i>=0.02, respectively). Most cardiac hemodynamic parameters, including peripheral arterial blood pressure and CAP, decreased significantly (<i>p</i> < 0.02 and <i>p</i> < 0.001, respectively) after LD intake in the PD group. Disease subtype, duration, and severity did not affect any of the hemodynamic parameters. When NMS were evaluated, patients with psychosis and dementia showed higher baseline parameters.</p><p><strong>Conclusion: </strong>Loss of postganglionic noradrenergic innervation is well-known with PD. Several cardiac hemodynamic parameters were affected, suggesting cardiac autonomic dysfunction in these patients. The data obtained were independent of disease severity, duration, and subtype. After LD intake, most of these parameters decreased, which might have a positive effect on the vascular burden.</p>\",\"PeriodicalId\":19907,\"journal\":{\"name\":\"Parkinson's Disease\",\"volume\":\" \",\"pages\":\"6723950\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2022-07-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296341/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Parkinson's Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/2022/6723950\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Parkinson's Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2022/6723950","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:心血管自主神经功能障碍是帕金森病(PD)患者常见的一种导致血流动力学紊乱的疾病。中央主动脉压(CAP)是主动脉根部的收缩压(SBP)。在年轻人中,CAP低于外周动脉血压。在老年人中,CAP和外周动脉血压之间的差异随着动脉僵硬程度的不同而减小。在AS患者中,CAP增加。因此,CAP被认为是as的一个指标。目的:比较帕金森病患者与对照组AS的CAP及其他血流动力学参数。我们还旨在评估左旋多巴(LD)摄入后这些血流动力学参数的变化。方法:选取82例PD患者和76例健康对照。记录年龄、性别、病程、疾病亚型、Hoehn-Yahr分期(H&Y)和非运动症状(NMS)。使用TensioMed Software v.3.0.0.1测量CAP、外周动脉压、脉压(PP)、心率(HR)、平均动脉压(MAP)、增强指数(AI)、脉搏波速、射血时间。所有患者均接受LD治疗,并在LD摄入前1小时和后1小时进行测量。结果:PD组外周血压和CAP基线值明显高于对照组(p < 0.001, p=0.02)。PD组大多数心脏血流动力学参数,包括外周动脉血压和CAP,在摄入LD后显著降低(p < 0.02和p < 0.001)。疾病亚型、病程和严重程度不影响任何血流动力学参数。当NMS进行评估时,精神病和痴呆患者显示出更高的基线参数。结论:PD患者神经节后去肾上腺素能神经支配的丧失是众所周知的。一些心脏血流动力学参数受到影响,提示这些患者存在心脏自主神经功能障碍。获得的数据与疾病严重程度、持续时间和亚型无关。摄入LD后,这些参数大多下降,这可能对血管负荷有积极影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Central Aortic Pressure and Arterial Stiffness in Parkinson's Disease: A Comparative Study.

Central Aortic Pressure and Arterial Stiffness in Parkinson's Disease: A Comparative Study.

Central Aortic Pressure and Arterial Stiffness in Parkinson's Disease: A Comparative Study.

Background: Cardiovascular autonomic dysfunction, which leads to hemodynamic disorders, is commonly observed in patients with Parkinson's disease (PD). Central aortic pressure (CAP) is the systolic blood pressure (SBP) at the root of the aorta. In young people, CAP is lower than peripheral arterial blood pressure. In older people, the difference between CAP and peripheral arterial blood pressure decreases depending on the extent of arterial stiffness (AS). In patients with AS, CAP increases. CAP is thus regarded as an indicator of AS.

Objective: To compare CAP and other hemodynamic parameters for AS between patients with Parkinson's disease and control group. We also aimed to evaluate changes in these hemodynamic parameters after the levodopa (LD) intake.

Methods: We included 82 patients with PD and 76 healthy controls. Age, sex, disease duration, disease subtype, Hoehn-Yahr stage (H&Y), and nonmotor symptoms (NMS) were documented. TensioMed Software v.3.0.0.1 was used to measure CAP, peripheral arterial blood pressure, pulse pressure (PP), heart rate (HR), mean arterial pressure (MAP), augmentation index (AI), pulse wave velocity, and ejection time. All patients were being treated with LD, and measurements were performed 1 h before and 1 h after LD intake.

Results: Baseline peripheral arterial blood pressure and CAP values were significantly higher in the PD group than in the control group (p < 0.001 and p=0.02, respectively). Most cardiac hemodynamic parameters, including peripheral arterial blood pressure and CAP, decreased significantly (p < 0.02 and p < 0.001, respectively) after LD intake in the PD group. Disease subtype, duration, and severity did not affect any of the hemodynamic parameters. When NMS were evaluated, patients with psychosis and dementia showed higher baseline parameters.

Conclusion: Loss of postganglionic noradrenergic innervation is well-known with PD. Several cardiac hemodynamic parameters were affected, suggesting cardiac autonomic dysfunction in these patients. The data obtained were independent of disease severity, duration, and subtype. After LD intake, most of these parameters decreased, which might have a positive effect on the vascular burden.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Parkinson's Disease
Parkinson's Disease CLINICAL NEUROLOGY-
CiteScore
5.80
自引率
3.10%
发文量
0
审稿时长
18 weeks
期刊介绍: Parkinson’s Disease is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the epidemiology, etiology, pathogenesis, genetics, cellular, molecular and neurophysiology, as well as the diagnosis and treatment of Parkinson’s disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信